ObsEva (NASDAQ:OBSV) Now Covered by Analysts at StockNews.com

Investment analysts at StockNews.com assumed coverage on shares of ObsEva (NASDAQ:OBSV) in a note issued to investors on Saturday. The firm set a “hold” rating on the stock.

ObsEva Price Performance

ObsEva has a 1-year low of $0.08 and a 1-year high of $2.14. The stock has a market cap of $7.94 million, a PE ratio of -0.11 and a beta of 0.68.

About ObsEva

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.